|
|
| MRD / Regn No. |
: SG004663 |
Date |
: 11/07/2026 |
| Patient Name |
: Bushra Zafar |
Age & Gender |
: 35 Yrs. / Female |
| Contact No. |
: 9038752 665 |
UHID |
: |
| Ht / Wt / BMI |
: 166 / 96 / 34.84 |
BP S / BP D |
: 132 / 92 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
PREGANACY (11/Jul/2026) | TYPE 2 DIABETES (11/Jul/2026) | |
| Salient Investigations |
: |
CREATININE: 0.5 | EGFR EGLOMERULAR FILTRATION RATE: 150.29 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 182 mg/dL | HB HEMOGLOBIN: 12.5 g/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 10.5 % | POST PRANDIAL GLUCOSE (2HPP): 207 mg/dL | TSH THYROID STIMULATING HORMONE: 3.38 mIU/L |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
TABLET THYROXINE 25 MCG
THYRONORM 25 MCG
Medicine For LOW THYROID |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
| MUST BE TAKEN ON AN EMPTY STOMACH. COFFEE TEA OR BREAKFAST MUST BE TAKEN ONLY AFTER 30 MINUTES. OTHER DRUGS CAN INTERFERE WITH THE ABSORPTION OF THYROXINE | |
|
2 |
METFORMIN SR 1000 MG
GLYCOMET SR |
PO |
0-0-1 |
BEFORE DINNER
|
TILL NEXT VISIT |
|
|
3 |
INJECTION DEGLUDEC (INJ U100)
TRESIBA
Medicine For DIABETES |
SQ |
0-0-14 |
AT BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
4 |
INJECTION ASPART (INJ U100)
NOVORAPID (INJ)
Medicine For DIABETES |
SQ |
0-8-0 |
BEFORE LUNCH
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 11/Oct/2026 |
| Tests Suggested For Next Visit |
: SMBG,HBA1C-HPLC METHOD,TSH |
| |
|
| |
|
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal /
54020
This is a Computer generated Prescription |
Powered By:  |